Immediate Impact
3 from Science/Nature 65 standout
Citing Papers
Targeted protein degradation: from mechanisms to clinic
2024 Standout
Understanding tumour endothelial cell heterogeneity and function from single-cell omics
2023 Standout
Works of Lea Latham being referenced
Phase II Trial of Bevacizumab, Thalidomide, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
2010
Pre‐clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen‐independent prostate cancer
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Lea Latham | 60 | 155 | 170 | 111 | 17 | 389 | |
| Raffaella Bitossi | 90 | 311 | 183 | 73 | 21 | 431 | |
| Shinya Maita | 83 | 137 | 146 | 106 | 23 | 365 | |
| Sarah Morgan | 52 | 231 | 106 | 149 | 12 | 416 | |
| Annelies Verbiest | 55 | 132 | 231 | 168 | 30 | 369 | |
| Shinji Katsushima | 92 | 83 | 130 | 73 | 21 | 438 | |
| Keith L. Shulman | 61 | 162 | 63 | 52 | 14 | 340 | |
| Fiona Hand | 74 | 121 | 72 | 89 | 17 | 401 | |
| Kevin Forsythe | 110 | 76 | 140 | 55 | 13 | 416 | |
| Hiroaki Muguruma | 27 | 223 | 153 | 206 | 15 | 406 | |
| Hy-De Lee | 60 | 224 | 58 | 113 | 16 | 400 |
All Works
Loading papers...